Although the cellular prion protein (PrP C ) is expressed in the enteric nervous system and lamina propria, its function(s) in the gut is unknown. Because PrP C may exert a cytoprotective effect in response to various physiologic stressors, we hypothesized that PrP C expression levels might modulate the severity of experimental colitis. We evaluated the course of dextran sodium sulfate (DSS)-induced colitis in hemizygous Tga20 transgenic mice (approximately sevenfold overexpression of PrP C ), Prnp ؊/؊ mice, and wild-type mice. On day 7, colon length, disease severity, and histologic activity indices were determined. Unlike DSS-treated wild-type and Prnp ؊/؊ animals, PrP C overexpressing mice were resistant to colitis induction, exhibited much milder histopathologic features, and did not exhibit weight loss or colonic shortening. In keeping with these results, pro-survival molecule expression and/or phosphorylation levels were elevated in DSStreated Tga20 mice, whereas pro-inflammatory cytokine production and pSTAT3 levels were reduced. In contrast, DSS-treated Prnp ؊/؊ mice exhibited increased BAD protein expression and a cytokine expression profile predicted to favor inflammation and differentiation. PrP C expression from both the endogenous Prnp locus or the Tga20 transgene was increased in the colons of DSStreated mice. Considered together, these findings demonstrate that PrP C has a previously unrecognized cytoprotective and/or anti-inflammatory function within the murine colon.